United States · 
Who invested in Attovia Therapeutics?
Attovia Therapeutics's investors include Cormorant Asset Management, Redmile Group, Sanofi and Illumina Ventures.
United States · Series C startup
Who invested in Attovia Therapeutics
Funding summaryUpdated 26 Oct 2026
$90Mraised across 1 round since 2025, from 1 source
- Latest round
- Series C, $90MApr 2025
- Investors
- 4
The rounds
- Apr 2025
Founders and team
From Attovia Therapeutics's own website: 1 founder, 4 on the team.
Lassen TherapeuticsCSO and Co-Founder
- Petter VeibyChief Scientific Officer
- Steven ChanChief Financial Officer
- John W. SmitherDirector
- Pioneering MedicinesDirector of Clinical Research
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Attovia Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Attovia Therapeutics
How much has Attovia Therapeutics raised?
Attovia Therapeutics has raised $90M across 1 round since 2025.
When did Attovia Therapeutics last raise?
Attovia Therapeutics's most recent round was a Series C of $90M in Apr 2025.
What was Attovia Therapeutics's biggest round?
Its most recent round, $90M in Apr 2025, is also its largest on record.
Who backed Attovia Therapeutics first?
Attovia Therapeutics's first round on record, in Apr 2025, was backed by Cormorant Asset Management, Redmile Group and Sanofi and 1 others.
What stage is Attovia Therapeutics at?
Attovia Therapeutics's latest named round is a Series C, in Apr 2025.
Where is Attovia Therapeutics based?
Attovia Therapeutics is based in the United States.
Companies like Attovia Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.